Related stories
Bristol Myers beats quarterly estimates, raises full-year sales outlook
Bristol Myers reported quarterly results above expectations and raised its full-year sales forecast, citing strong performance from new drugs.
M impact | EARNINGS | Oct 30, 2026, 01:48 AM UTC
Kingsgate sets FY27 production guidance
Kingsgate Consolidated forecasts FY27 production of 75–85koz of gold, 650–750koz of silver and 82–93koz of AUEQ.
M impact | EARNINGS | Oct 30, 2026, 01:47 AM UTC
Metsä Board Sees Annual Investment Below the Reported Threshold in 2026–2030
Metsä Board expects annual investment to be well below the reported threshold from 2026 through 2030.
L impact | EARNINGS | Oct 30, 2026, 01:47 AM UTC
Vamos Reports Net Profit in 3Q26, Up 199% From 3Q25
Vamos reported net profit in 3Q26, up 199% from 3Q25.
M impact | EARNINGS | Oct 30, 2026, 01:42 AM UTC
AIA Group 3Q New Business Value $1.42B vs. $1.48B
AIA Group reported third-quarter value of new business of $1.42 billion, compared with $1.48 billion.
L impact | EARNINGS | Oct 30, 2026, 01:40 AM UTC
Vale Reports Lower Earnings Through September, Down 27% Year Over Year
Minera Vale reported earnings through September, 27% lower year over year.
M impact | EARNINGS | Oct 30, 2026, 01:34 AM UTC